These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7553688

  • 1. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
    Adluri S, Helling F, Ogata S, Zhang S, Itzkowitz SH, Lloyd KO, Livingston PO.
    Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688
    [Abstract] [Full Text] [Related]

  • 2. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD, Reddish MA, Koganty RR, Longenecker BM.
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
    [Abstract] [Full Text] [Related]

  • 3. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM, Reddish M, Koganty R, MacLean GD.
    Adv Exp Med Biol; 1994 Jan; 353():105-24. PubMed ID: 7527178
    [Abstract] [Full Text] [Related]

  • 4. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G, Howard L, Cappello S, Koganty RR, Qiu D, Longenecker BM, Reddish MA, Lloyd KO, Livingston PO.
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO.
    Cancer Immunol Immunother; 2003 Oct; 52(10):608-16. PubMed ID: 12811527
    [Abstract] [Full Text] [Related]

  • 9. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T.
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [Abstract] [Full Text] [Related]

  • 10. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
    Zhang S, Walberg LA, Ogata S, Itzkowitz SH, Koganty RR, Reddish M, Gandhi SS, Longenecker BM, Lloyd KO, Livingston PO.
    Cancer Res; 1995 Aug 01; 55(15):3364-8. PubMed ID: 7614472
    [Abstract] [Full Text] [Related]

  • 11. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.
    MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM.
    Cancer Immunol Immunother; 1993 Aug 01; 36(4):215-22. PubMed ID: 8439984
    [Abstract] [Full Text] [Related]

  • 12. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.
    Miles DW, Towlson KE, Graham R, Reddish M, Longenecker BM, Taylor-Papadimitriou J, Rubens RD.
    Br J Cancer; 1996 Oct 01; 74(8):1292-6. PubMed ID: 8883420
    [Abstract] [Full Text] [Related]

  • 13. Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.
    Miles D, Roché H, Martin M, Perren TJ, Cameron DA, Glaspy J, Dodwell D, Parker J, Mayordomo J, Tres A, Murray JL, Ibrahim NK, Theratope® Study Group.
    Oncologist; 2011 Oct 01; 16(8):1092-100. PubMed ID: 21572124
    [Abstract] [Full Text] [Related]

  • 14. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
    O'Boyle KP, Markowitz AL, Khorshidi M, Lalezari P, Longenecker BM, Lloyd KO, Welt S, Wright KE.
    Hybridoma; 1996 Dec 01; 15(6):401-8. PubMed ID: 8985750
    [Abstract] [Full Text] [Related]

  • 15. Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies.
    Livingston P, Zhang S, Adluri S, Yao TJ, Graeber L, Ragupathi G, Helling F, Fleisher M.
    Cancer Immunol Immunother; 1997 Jan 01; 43(6):324-30. PubMed ID: 9067403
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
    Ragupathi G, Damani P, Srivastava G, Srivastava O, Sucheck SJ, Ichikawa Y, Livingston PO.
    Cancer Immunol Immunother; 2009 Sep 01; 58(9):1397-405. PubMed ID: 19190907
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
    Ragupathi G, Cappello S, Yi SS, Canter D, Spassova M, Bornmann WG, Danishefsky SJ, Livingston PO.
    Vaccine; 2002 Jan 15; 20(7-8):1030-8. PubMed ID: 11803062
    [Abstract] [Full Text] [Related]

  • 18. Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy.
    Reddish MA, MacLean GD, Poppema S, Berg A, Longenecker BM.
    Cancer Immunol Immunother; 1996 Jun 15; 42(5):303-9. PubMed ID: 8706053
    [Abstract] [Full Text] [Related]

  • 19. Clinical development of the STn-KLH vaccine (Theratope).
    Ibrahim NK, Murray JL.
    Clin Breast Cancer; 2003 Feb 15; 3 Suppl 4():S139-43. PubMed ID: 12620151
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.